Literature DB >> 4136044

Recurrent experimental allergic encephalomyelitis in the Lewis rat.

D E McFarlin, S E Blank, R F Kibler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4136044

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  23 in total

1.  Age dependence of clinical and pathological manifestations of autoimmune demyelination. Implications for multiple sclerosis.

Authors:  M E Smith; N L Eller; H F McFarland; M K Racke; C S Raine
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

2.  The myelin basic protein gene is not a major susceptibility locus for multiple sclerosis in Italian patients.

Authors:  M Eoli; M Pandolfo; C Milanese; P Gasparini; A Salmaggi; M Zeviani
Journal:  J Neurol       Date:  1994-10       Impact factor: 4.849

Review 3.  The evidence justifying immunosuppression therapy in multiple sclerosis.

Authors:  J Mertin
Journal:  Proc R Soc Med       Date:  1977-12

4.  Immunocytochemical study of myelin-associated glycoprotein (MAG), basic protein (BP), and glial fibrillary acidic protein (GFAP) in chronic relapsing experimental allergic encephalomyelitis (EAE).

Authors:  H D Webster; H Shii; H Lassmann
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

5.  Interleukin-12 induces relapse in experimental allergic encephalomyelitis in the Lewis rat.

Authors:  T Smith; A K Hewson; C I Kingsley; J P Leonard; M L Cuzner
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

Review 6.  Characterization and distribution of lymphocyte subpopulations in multiple sclerosis plaques versus autoimmune demyelinating lesions.

Authors:  U Traugott
Journal:  Springer Semin Immunopathol       Date:  1985

7.  Immunologic determinants of experimental neurologic autoimmune disease and approaches to the multiple sclerosis problem.

Authors:  P Y Paterson; R S Fujinami; E D Day; V A Varitek; M D Pescovitz; J Kelly; L Lorand
Journal:  Trans Am Clin Climatol Assoc       Date:  1978

8.  The spleen is required for the suppression of experimental allergic encephalomyelitis by prostaglandin precursors.

Authors:  J Mertin; A Stackpoole
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

9.  The role of the neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis in the rat.

Authors:  D Mason; I MacPhee; F Antoni
Journal:  Immunology       Date:  1990-05       Impact factor: 7.397

10.  Identification in silico and experimental validation of novel phosphodiesterase 7 inhibitors with efficacy in experimental autoimmune encephalomyelitis mice.

Authors:  Miriam Redondo; Valle Palomo; José Brea; Daniel I Pérez; Rocío Martín-Álvarez; Concepción Pérez; Nuria Paúl-Fernández; Santiago Conde; María Isabel Cadavid; María Isabel Loza; Guadalupe Mengod; Ana Martínez; Carmen Gil; Nuria E Campillo
Journal:  ACS Chem Neurosci       Date:  2012-08-08       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.